811-P: Durable Insulin Pumps vs. Multiple Daily Injections for Type 1 Diabetes: Health Care Utilization and A1C

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 811-P
Author(s):  
MONA SHAH ◽  
CYRUS ZHU ◽  
KAEL WHERRY
Author(s):  
Ransome Eke ◽  
Xin (Thomas) Yang ◽  
Kiersten L. Bond ◽  
Courtney Hanson ◽  
Caroline Jenkins ◽  
...  

Author(s):  
BRANDON WEN BING CHUA ◽  
XIN YAN LIM ◽  
KAR MEN POH ◽  
JAMIE STEPHANIE CALEB ◽  
MCVIN HUA HENG CHEEN ◽  
...  

Objective: Optimizing glycemic control is challenging with insulin non-adherence. This study aimed to characterize the prevalence of non-adherence among Singaporean pediatric patients with type 1 diabetes mellitus (T1DM) and investigate its associated outcomes. Methods: Singaporean patients with T1DM aged ≤18 years old with ≥1 year of insulin prescription between 2012 and 2016 were included in this retrospective, single-center longitudinal study. Patients on insulin pumps were excluded from the study. Non-adherence was defined as medication possession ratio (MPR) <100%. Glycemic control was defined using mean hemoglobin A1c (HbA1c) within the study period. Health-care utilization was defined as the number of outpatients, inpatient, and emergency visits. The t-test, Chi-square test, logistic regression, and Poisson regression were used to analyze means, proportions, factors associated with non-adherence, and association of non-adherence and health-care utilization, respectively. Sensitivity analyses were performed for MPR thresholds of 80% and 95%. Results: A total of 206 patients were included in this study. Non-adherent patients were older, had a longer duration of diabetes since diagnosis and shorter duration of follow-up. Gender, race, financial class, and number of concurrent medications were comparable between groups. The prevalence of non-adherence was 34.0% (95% confidence interval [CI]: 27.9–40.7%). Non-adherent patients had a higher average HbA1c (non-adherent: 9.6% [2.1] vs. adherent: 8.6% [1.3], p<0.001). Non-adherence was not associated with health-care utilization. Patients with >5 years of diabetes were more likely to be non-adherent. Conclusion: Non-adherence defined as MPR <100% is associated with poorer glycemic control. Further interventions may focus on patients with >5 years of diabetes to improve their adherence to insulin therapy.


2013 ◽  
pp. 761 ◽  
Author(s):  
Katharine C Garvey ◽  
Jonathan Finkelstein ◽  
Lori Laffel ◽  
Victoria Ochoa ◽  
Wolfsdorf ◽  
...  

2003 ◽  
Vol 32 (1) ◽  
pp. 1-16 ◽  
Author(s):  
Max P. Cote ◽  
Larry L. Mullins ◽  
Valerie Hartman ◽  
Ahna Hoff ◽  
Benjamin H. K. Balderson ◽  
...  

2016 ◽  
Vol 11 (1) ◽  
pp. 50-58 ◽  
Author(s):  
Isabelle Steineck ◽  
Ajenthen Ranjan ◽  
Kirsten Nørgaard ◽  
Signe Schmidt

Hypoglycemia can lead to seizures, unconsciousness, or death. Insulin pump treatment reduces the frequency of severe hypoglycemia compared with multiple daily injections treatment. The addition of a continuous glucose monitor, so-called sensor-augmented pump (SAP) treatment, has the potential to further limit the duration and severity of hypoglycemia as the system can detect and in some systems act on impending and prevailing low blood glucose levels. In this narrative review we summarize the available knowledge on SAPs with and without automated insulin suspension, in relation to hypoglycemia prevention. We present evidence from randomized trials, observational studies, and meta-analyses including nonpregnant individuals with type 1 diabetes mellitus. We also outline concerns regarding SAPs with and without automated insulin suspension. There is evidence that SAP treatment reduces episodes of moderate and severe hypoglycemia compared with multiple daily injections plus self-monitoring of blood glucose. There is some evidence that SAPs both with and without automated suspension reduces the frequency of severe hypoglycemic events compared with insulin pumps without continuous glucose monitoring.


Sign in / Sign up

Export Citation Format

Share Document